On December 2, Yinfeng Biology Group and Xi'an Huayi Medical plastic aesthetic hospital Co., Ltd. successfully held a signing ceremony for the strategic cooperation intention. The two parties will uphold this cooperation intention and carry out in-depth cooperation in health management, cosmetic anti-fading and other fields.

Xu Jianxin, Chairman and General Manager of Xi'an Huayi Medical plastic aesthetic hospital, Zhu Jiang, Deputy General Manager, Zhang Qinyan, Chief Financial Officer, Prof. Feng Xinghua, Dean (Professor), Liu Xiangshan, Professor in Rejuvenation Center, Pang Yong, Acting President of Yinfeng Biotechnology Group, Li Dezhu, Vice President and Chief Financial Officer, Pan Feng, General Manager of Shaanxi Stem Cell Engineering Co., Ltd., Wang Zhantao, Project Manager, and Xu Wenqiang, Project Supervisor attended the signing ceremony.

Xi'an Huayi Medical plastic aesthetic hospital is a level-two provincial specialist cosmetology hospital that integrates medical beauty, anti-fading, and accurate detection. Many aspects have been explored in terms of immune cells and stem cells. According to the letter of intent for strategic cooperation between Yinfeng Biotechnology and Xi'an Huayi Medical Plastic Aesthetic Hospital  Co., Ltd, the two sides will cooperate in the aspects of stem cells, immune cell preparation and storage technology services, transformation of stem cell technology achievement , application of gene sequencing technology, etc. and make a joint efforts to technical and service that can prevent chronic disease, sub-health care, and supported the health management and cosmetic rejuvenation  for improving the health of the population in Xi'an.

On the day of signing the contract, accompanied by Pang Yong, Acting President of Yinfeng Biotechnology Group, Chairman Xu Jianxin visited Umbilical Cord Blood Bank in Shandong, Shandong Yinfeng Life Science Research Institute, Yinfeng Gene Technology Laboratory, and Qilu Cell Therapy Laboratory, and get to know what research achievements of the Yinfeng Biotechnology Group were obtained in stem cell storage, cryogenic medicine, gene sequencing, and cell therapy. For the strong R&D capabilities and corporate strength of Yinfeng Biotechnology Group, Chairman Xu Jianxin and his party gave unanimous praise.